ABSTRACT

Key Research Question: Antimicrobial Utilization in COVID-19 Patients for Suspected Coinfection or Superinfection   [open pdf - 360KB]

From the Context: "[1] Multiple jurisdictions are creating COVID-19 [coronavirus disease 2019] care pathways for patients in various care settings, many of which involve antibacterial therapy. [2] This review was requested to assess current data on the incidence of co-infections at presentation or bacterial or fungal superinfection that may influence guideline creation. [3] Literature on hospitalized patients with other viral respiratory tract infections suggests high rates of antimicrobial use without obvious benefit."

Author:
Publisher:
Date:
2020-05-06
Series:
Copyright:
2020 Alberta Health Services. Posted here with permission. Document is under a Creative Commons license and requires proper attribution and noncommercial use to be shared: [https://creativecommons.org/licenses/by-nc-nd/4.0]
Retrieved From:
Alberta Health Services: https://www.albertahealthservices.ca/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations